Skip to main content
main-content

01.06.2014 | Original Article | Ausgabe 6/2014

Annals of Hematology 6/2014

Analysis of class I and II aberrations in Iraqi childhood acute myeloid leukemia using filter paper cards

Zeitschrift:
Annals of Hematology > Ausgabe 6/2014
Autoren:
Lika’a Fasih Y. Al-Kzayer, Le Thanh N. Uyen, Mazin Faisal Al-Jadiry, Salma Abbas Al-Hadad, Safaa A. Faraj Al-Badri, Hasanein Habeeb Ghali, Najiha Ahmed Ameen, Tingting Liu, Kazuyuki Matsuda, Jaafar M. H. Abdulkadhim, Tariq Abadi Al-Shujairi, Zead Ismael I. K. Matti, Janan Ghalib Hasan, Hussam M. Salih Al-Abdullah, Mouroge H. Al-Ani, Paiman Ali I. Saber, Hisham Maree Khalil, Toshi Inoshita, Minoru Kamata, Kenichi Koike, Kazuo Sakashita
Wichtige Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1007/​s00277-014-2007-2) contains supplementary material, which is available to authorized users.

Abstract

The lack of molecular diagnosis in the field of cancer in Iraq has motivated us to perform a genetic analysis of pediatric acute myelogenous leukemia (AML), including class I and II aberrations. Peripheral blood or bone marrow cells were collected from 134 AML children aged ≤15 years. Flinders Technology Associates (FTA) filter paper cards were used to transfer dried blood samples from five Iraqi hospitals to Japan. DNA sequencing was performed to identify class I mutations. Nested RT-PCR was used to detect class II aberrations, except that MLL rearrangement was detected according to long distance inverse-PCR. NPM1 and FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) mutations were analyzed by GeneScan using DNA template. Among 134 Iraqi pediatric AML samples, the most prevalent FAB subtype was M2 (33.6 %) followed by M3 (17.9 %). Class I mutations: 20 (14.9 %), 8 (6.0 %), and 8 (6.0 %) patients had FLT3-ITD, FLT3-TKD, and KIT mutations, respectively. Class II mutations: 24 (17.9 %), 19 (14.2 %), and 9 (6.7 %) children had PML-RARA, RUNX1-RUNX1T1, and CBFB-MYH11 transcripts, respectively. MLL rearrangements were detected in 25 (18.7 %) patients. NPM1 mutation was detected in seven (5.2 %) cases. Collectively, approximately 30 % of AML children were proved to carry favorable prognostic genetic abnormalities, whereas approximately 10 % had high FLT3-ITD allelic burden and needed a special treatment plan including allogeneic hematopoietic stem cell transplantation. Acute promyelocytic leukemia (APL) was frequent among Iraqi pediatric AML. It is likely that molecular diagnosis using FTA cards in underdeveloped countries could guide doctors towards an appropriate treatment strategy.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de. Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Weitere Produktempfehlungen anzeigen
Zusatzmaterial
ESM 1 (PDF 341 kb)
277_2014_2007_MOESM1_ESM.pdf
ESM 2 (PDF 677 kb)
277_2014_2007_MOESM2_ESM.pdf
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 6/2014

Annals of Hematology 6/2014 Zur Ausgabe
  1. Sie können e.Med Innere Medizin 14 Tage kostenlos testen (keine Print-Zeitschrift enthalten). Der Test läuft automatisch und formlos aus. Es kann nur einmal getestet werden.

  2. Das kostenlose Testabonnement läuft nach 14 Tagen automatisch und formlos aus. Dieses Abonnement kann nur einmal getestet werden.

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise